We show that properly engineered amorphous Fe-Gd alloy thin films with perpendicular magnetic anisotropy (PMA) exhibit bound pairs of like-polarity, opposite helicity skyrmions at room temperature. Magnetic mirror symmetry planes present in the stripe phase, instead of chiral exchange, determine the internal skyrmion structure and the net achirality of the skyrmion phase. Our study shows that stripe domain engineering in amorphous alloy thin films may enable the creation of skyrmion phases with technologically desirable properties.
The dynamic response of dipole skyrmions in Fe/Gd multilayer films is investigated by ferromagnetic resonance measurements and compared to micromagnetic simulations. We detail thickness and temperature dependent studies of the observed modes as well as the effects of magnetic field history on the resonant spectra. Correlation between the modes and the magnetic phase maps constructed from real-space imaging and scattering patterns allows us to conclude the resonant modes arise from local topological features such as dipole skyrmions but does not depend on the collective response of a closed packed lattice of these chiral textures. Using, micromagnetic modeling, we are able to quantitatively reproduce our experimental observations which suggests the existence of localized spin-wave modes that are dependent on the helicity of the dipole skyrmion. We identify four localized spin wave excitations for the skyrmions that are excited under either in-plane or out-of-plane r.f. fields. Lastly we show that dipole skyrmions and non-chiral bubble domains exhibit qualitatively different localized spin wave modes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.